» Articles » PMID: 22426479

Isolation of MiRNAs That Target EGFR MRNA in Human Lung Cancer

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2012 Mar 20
PMID 22426479
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Lung cancer, predominantly non-small cell lung cancer (NSCLC), remains the leading cause of cancer-related deaths worldwide. Although epidermal growth factor receptor (EGFR) signaling is important and well studied with respect to NSCLC progression, little is known about how miRNAs mediate EGFR signaling to modulate tumorigenesis. To identify miRNAs that target EGFR, we performed a bioinformatics analysis and found that miR-542-5p down-regulates EGFR mRNA and protein expression in human lung cancer cells (H3255, A549, Hcc827). We observed increases in EGFR association with Ago2 in miR-542-5p-transfected cells. Interestingly, we observed an inverse correlation of miR-542-5p expression and EGFR protein levels in human lung cancer tissue samples, suggesting that miR-542-5p directly targets EGFR mRNA. Furthermore, we found that miR-542-5p inhibited the growth of human lung cancer cells. Our findings suggest that miR-542-5p may act as an important modulator of EGFR-mediated oncogenesis, with potential applications as a novel therapeutic target in lung cancer.

Citing Articles

Hypoxia-induced paclitaxel resistance in cervical cancer modulated by miR-100 targeting of USP15.

Nishi H, Ono M, Ohno S, Yamanaka Z, Sasaki T, Ohyashiki K Gynecol Oncol Rep. 2023; 45:101138.

PMID: 36714373 PMC: 9873580. DOI: 10.1016/j.gore.2023.101138.


Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands.

Hassanein S, Ibrahim S, Abdel-Mawgood A Int J Mol Sci. 2021; 22(22).

PMID: 34830377 PMC: 8621388. DOI: 10.3390/ijms222212496.


miR-542-5p Attenuates Fibroblast Activation by Targeting Integrin α6 in Silica-Induced Pulmonary Fibrosis.

Yuan J, Li P, Pan H, Li Y, Xu Q, Xu T Int J Mol Sci. 2018; 19(12).

PMID: 30467286 PMC: 6320929. DOI: 10.3390/ijms19123717.


Effect of miR‑146a‑5p on tumor growth in NSCLC using chick chorioallantoic membrane assay and bioinformatics investigation.

Huang W, Cen W, He R, Xie Y, Zhang Y, Li P Mol Med Rep. 2017; 16(6):8781-8792.

PMID: 28990079 PMC: 5779957. DOI: 10.3892/mmr.2017.7713.


The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.

He R, Li X, Liang L, Xie Y, Luo D, Ma J BMC Cancer. 2017; 17(1):655.

PMID: 28927388 PMC: 5606087. DOI: 10.1186/s12885-017-3646-1.